Skip to main content
. 2023 May 26;9(6):e16754. doi: 10.1016/j.heliyon.2023.e16754

Table 9.

Physicochemical properties of identified compounds from LSNHF for good oral bioavailability.

Compounds Lipinski's rule
Lipinski's violation (≤1) Veber rules
MW (<500 g/mol) HBA (<10) HBD (<5) Log P (≤5) nRB (≤10) TPSA (≤140 Å2)
Butanoic acid, 2-methyl- 102.13 2 1 0.97 0 2 37.30
Phenol, 2-methoxy-4-(2-propenyl)-, acetate 206.24 3 0 2.55 0 5 35.53
9,9-Dimethoxybicyclo [3.3.1]nona-2,4-dione 212.24 4 0 1.04 0 2 52.60
Undec-10-ynoic acid, tetradecyl ester 378.63 2 0 7.97 0 22 26.30
7-Hexadecenal, (Z)- 238.41 1 0 5.11 0 13 17.07
2-Tridecenoic acid, (E)- 212.33 2 1 3.93 0 10 37.3
Oleic Acid 282.46 2 1 5.71 1 15 37.30
l-(+)-Ascorbic acid 2,6-dihexadecanoate 652.94 8 2 9.57 2 34 119.36
Eicosanoic acid 312.53 2 1 6.62 1 18 37.30
Docosane, 1,22-dibromo- 468.39 0 0 9.10 1 21 0.00
Cholesterol margarate 639.09 2 1 12.44 2 22 26.30

Abbreviation: MW: Molecular weight; HBA:hydrogen-bond acceptors; HBD: hydrogen-bond donors; Log P: lipophilicity; nRB: number of rotatable bonds; TPSA: topological polar surface area.